Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)

Name: Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)
Published: 2007
License: Public Domain

Stanford University · 2007

ClinicalTrials.gov · Datasets · License: Public Domain · 2007

Open Source ↗

epstein-barr-virus fatigue

chronic fatigue syndrome, fatigue, valganciclovir, valcyte, epstein-barr virus, ebv, human herpes virus 6, hhv 6, herpes viruses, herpes, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)

Related documents